NCIt definition : A synthetic hydroxamic acid derivative with antineoplastic activity. Vorinostat, a
second generation polar-planar compound, binds to the catalytic domain of the histone
deacetylases (HDACs). This allows the hydroxamic moiety to chelate zinc ion located
in the catalytic pockets of HDAC, thereby inhibiting deacetylation and leading to
an accumulation of both hyperacetylated histones and transcription factors. Hyperacetylation
of histone proteins results in the upregulation of the cyclin-dependant kinase p21,
followed by G1 arrest. Hyperacetylation of non-histone proteins such as tumor suppressor
p53, alpha tubulin, and heat-shock protein 90 produces additional anti-proliferative
effects. This agent also induces apoptosis and sensitizes tumor cells to cell death
processes. Vorinostat crosses the blood-brain barrier.;
Alternative definition : NCI-GLOSS: A drug that is used to treat cutaneous T-cell lymphoma that does not get
better, gets worse, or comes back during or after treatment with other drugs. It is
also being studied in the treatment of other types of cancer. Vorinostat is a type
of histone deacetylase inhibitor.;
UNII : 58IFB293JI;
InChIKey : WAEXFXRVDQXREF-UHFFFAOYSA-N;
CAS number : 149647-78-9;
Drug name : Zolinza;
Molecule name : Suberoylanilide Hydroxamic Acid; Suberanilohydroxamic Acid; L-001079038; MSK-390;
Chemical formula : C14H20N2O3;
NSC code : 701852;
Codes from synonyms : CDR0000044908; CDR0000455153; CDR0000455152; CDR0000514187; 09559; 545;